These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Therapeutic concepts in Amyotrophic Lateral Sclerosis (ALS)]. Ludolph AC Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S21. PubMed ID: 24242034 [No Abstract] [Full Text] [Related]
29. Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis. Ginsberg GM; Lev B Pharmacoeconomics; 1997 Nov; 12(5):578-84. PubMed ID: 10174324 [TBL] [Abstract][Full Text] [Related]
30. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? Bellingham MC CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142 [TBL] [Abstract][Full Text] [Related]
31. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model. Conde B; Winck JC; Azevedo LF Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082 [TBL] [Abstract][Full Text] [Related]
33. Current Therapy of Drugs in Amyotrophic Lateral Sclerosis. Lu H; Le WD; Xie YY; Wang XP Curr Neuropharmacol; 2016; 14(4):314-21. PubMed ID: 26786249 [TBL] [Abstract][Full Text] [Related]
35. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Turner M; Al-Chalabi A Neurology; 2002 Dec; 59(12):2012-3; author reply 2013. PubMed ID: 12499513 [No Abstract] [Full Text] [Related]
36. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Jaiswal MK Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496 [TBL] [Abstract][Full Text] [Related]
37. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M; J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433 [TBL] [Abstract][Full Text] [Related]
38. Slowing down ALS--is this good or bad? Munsat TL Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S19-22. PubMed ID: 11465919 [TBL] [Abstract][Full Text] [Related]
39. [Riluzole as a treatment for amyotrophic lateral sclerosis]. Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030 [TBL] [Abstract][Full Text] [Related]
40. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment. Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]